Accogli Andrea, Geraldo Ana Filipa, Piccolo Gianluca, Riva Antonella, Scala Marcello, Balagura Ganna, Salpietro Vincenzo, Madia Francesca, Maghnie Mohamad, Zara Federico, Striano Pasquale, Tortora Domenico, Severino Mariasavina, Capra Valeria
Division of Medical Genetics, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Diagnostic Neuroradiology Unit, Imaging Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Front Pediatr. 2022 Jan 14;9:794069. doi: 10.3389/fped.2021.794069. eCollection 2021.
Macrocephaly affects up to 5% of the pediatric population and is defined as an abnormally large head with an occipitofrontal circumference (OFC) >2 standard deviations (SD) above the mean for a given age and sex. Taking into account that about 2-3% of the healthy population has an OFC between 2 and 3 SD, macrocephaly is considered as "clinically relevant" when OFC is above 3 SD. This implies the urgent need for a diagnostic workflow to use in the clinical setting to dissect the several causes of increased OFC, from the benign form of familial macrocephaly and the Benign enlargement of subarachnoid spaces (BESS) to many pathological conditions, including genetic disorders. Moreover, macrocephaly should be differentiated by megalencephaly (MEG), which refers exclusively to brain overgrowth, exceeding twice the SD (3SD-"clinically relevant" megalencephaly). While macrocephaly can be isolated and benign or may be the first indication of an underlying congenital, genetic, or acquired disorder, megalencephaly is most likely due to a genetic cause. Apart from the head size evaluation, a detailed family and personal history, neuroimaging, and a careful clinical evaluation are crucial to reach the correct diagnosis. In this review, we seek to underline the clinical aspects of macrocephaly and megalencephaly, emphasizing the main differential diagnosis with a major focus on common genetic disorders. We thus provide a clinico-radiological algorithm to guide pediatricians in the assessment of children with macrocephaly.
巨头畸形影响着高达5%的儿科人群,其定义为头部异常增大,枕额周长(OFC)高于特定年龄和性别的平均值2个标准差(SD)以上。考虑到约2%-3%的健康人群OFC在2至3个标准差之间,当OFC高于3个标准差时,巨头畸形被认为具有“临床相关性”。这意味着迫切需要一种用于临床环境的诊断流程,以剖析OFC增加的多种原因,从家族性巨头畸形的良性形式和蛛网膜下腔良性扩张(BESS)到许多病理状况,包括遗传性疾病。此外,巨头畸形应与脑巨大症(MEG)相区分,脑巨大症仅指脑过度生长,超过标准差的两倍(3个标准差——“临床相关”脑巨大症)。虽然巨头畸形可能是孤立且良性的,也可能是潜在先天性、遗传性或后天性疾病的首个迹象,但脑巨大症很可能是由遗传原因导致的。除了头部大小评估外,详细的家族史和个人史、神经影像学检查以及仔细的临床评估对于做出正确诊断至关重要。在本综述中,我们试图强调巨头畸形和脑巨大症的临床方面,着重突出主要的鉴别诊断,重点关注常见的遗传性疾病。因此,我们提供了一种临床放射学算法,以指导儿科医生评估患有巨头畸形的儿童。